Eton Pharmaceuticals, Inc.'s (ETON) CEO Sean Brynjelsen on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/12/22
Analysts Estimate Eton Pharmaceuticals, Inc. (ETON) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 05/05/22
Eton Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022GlobeNewsWire • 05/03/22
Eton Pharmaceuticals Announces FDA Approval of Cysteine Hydrochloride InjectionGlobeNewsWire • 04/11/22
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/17/22
Eton Pharmaceuticals and ANI Pharmaceuticals Announce Commercial Availability of Carglumic Acid Tablets, the First and Only FDA-Approved Generic Version of Carbaglu® (carglumic acid)GlobeNewsWire • 12/20/21
Eton Pharmaceuticals' (ETON) CEO Sean Brynjelsen on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/16/21
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 11/16/21
Eton Pharmaceuticals Announces Co-Promotion Agreement with Tolmar Pharmaceuticals for ALKINDI SPRINKLE®GlobeNewsWire • 11/15/21
Eton Pharmaceuticals and Azurity Pharmaceuticals, Inc. Announce FDA Approval of EPRONTIA™ (topiramate) Oral SolutionGlobeNewsWire • 11/08/21
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks Investment Research • 11/04/21
Eton Pharmaceuticals to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021GlobeNewsWire • 11/03/21
Eton Pharmaceuticals Announces Acquisition of Approved Orphan Drug Product Carglumic AcidGlobeNewsWire • 10/28/21
Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/16/21
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 08/04/21
Eton Pharmaceuticals Buys US, Canadian Rights To Zeneo Hydrocortisone AutoinjectorBenzinga • 06/16/21
CROSSJECT : US & Canada licensing agreement with Eton Pharmaceuticals for Crossject's ZENEO® HydrocortisoneGlobeNewsWire • 06/16/21
Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone AutoinjectorGlobeNewsWire • 06/15/21